Poland· PL-100416810
Bevespi Aerosphere
A formoterol und glycopyrronium bromid product containing glycopyrronii bromidum + formoteroli fumaras dihydricus, registered in Poland by AstraZeneca AB. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Formoterol und glycopyrronium bromid is registered in 9 of 19 countries.
Countries holding a registration under ATC R03AL07 (formoterol und glycopyrronium bromid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Formoterol und glycopyrronium bromid · ATC R03AL07
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Glycopyrronii bromidum + Formoteroli fumaras dihydricus
- Manufacturer
- AstraZeneca AB
- Country
- Poland (PL)
- ATC code
- R03AL07
- ATC class
- Formoterol und Glycopyrronium bromid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol und glycopyrronium bromid in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/284d9117-1186-498f-bdfc-30c551719f6f GET /v1/drugs/284d9117-1186-498f-bdfc-30c551719f6f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol inhalacyjny, zawiesina",
"source": "urpl",
"strength": "7,2 mcg + 5 mcg",
"packaging": "Rp ¦ EU/1/18/1339/001 ¦ 131336\n1 poj. 120 dawek\nRp ¦ EU/1/18/1339/002 ¦ 137798\n3 poj. 120 dawek",
"substance": "Glycopyrronii bromidum 7.2 mcg + Formoteroli fumaras dihydricus 5 mcg",
"common_name": "Glycopyrronii bromidum + Formoteroli fumaras dihydricus",
"pl_product_id": "100416810",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about formoterol und glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.